NEW YORK, July 31, 2018 /PRNewswire/ --
According to data provided by Grand View Research, the global legal cannabis market is projected to reach USD 146.4 billion by end of 2025. Growing adoption of cannabis products for various medical applications such
as cancer, mental disorders, chronic pain and others are expected to drive revenue growth in the near future. The research
indicates that the legal cannabis industry has started gaining traction worldwide due to very high demand among consumers for
recreational and medical products. As a result, high public and private investments for research and the development of safer
forms of ingesting cannabis such as tinctures, oils, vapes and other edibles are expected to positively reinforce market growth.
CLS Holdings USA Inc. (OTC: CLSH), Invictus MD Strategies Corp. (OTC: IVITF), Vitality
Biopharma, Inc. (OTC: VBIO), Lexaria Bioscience Corp. (OTC: LXRP), The Supreme Cannabis Company, Inc. (OTC: SPRWF)
Canada has legalized cannabis nationally earlier this June and the U.S. is moving gradually
towards legalization. Earlier this year the state of California has legalized cannabis for
recreational purposes. Canada's new laws are expected to create an innovative environment.
According to a report by CBC, University of Waterloo entrepreneurship professor, Nada Basir, explained, "Where I think we're going to see a lot of startup activity around this new legislation
is in activities outside the traditional growth and transaction of the product… typically, historically, this is where we see
innovation really happen because it becomes the survival of the fittest, and to survive you're going to have to figure out how to
scale, how you can be more efficient, how you can save costs."
CLS Holdings USA Inc. (OTCQB: CLSH) announced last week the, "appointment of
Frank Tarantino as Chief Financial Officer. Mr. Tarantino brings big four public accounting and
private and public company management and financial expertise, which will be extremely beneficial in leading the Company through
its next phase in organic growth and acquisitions.
Mr. Tarantino stated, "I am pleased to join CLS post acquisition of Oasis Cannabis and look forward to working with the
executive team in its strategic transition into vertically integrated operations, and expanding its operations in Nevada and other key markets."
Mr. Tarantino has more than 18 years of executive management experience in public and private companies and six years of
experience in public accounting. Prior to joining CLS, Mr. Tarantino was the COO/CFO of Wild Things, an outdoor clothing
manufacturer and retailer serving the US Military and foreign governments. Prior to Wild Things, Mr. Tarantino worked as the Vice
President of Finance at Cornerstone Brands, an acquisition and holding company concentrating on high end, online and direct mail
retailers. Mr. Tarantino was involved with several acquisitions and managed the company's bank syndicated credit line, which
peaked at $135 million. Mr. Tarantino also worked on raising capital for both Wild Things and
Cornerstone Brands. In the early stages of his career, Mr. Tarantino worked as an auditor for Coopers and Lybrand, now
Pricewaterhouse Coopers, in the Boston office where he concentrated on auditing financial
institutions, banks, broker dealers and institutional investors.
Mr. Tarantino earned a BS in Accounting and Finance from Babson College, Wellesley, MA and earned his Certified Public Accountant Certificate from the State of Massachusetts."
Mr. Lamadrid has elected to resign due to personal considerations. CLS Chief Executive Officer Jeff
Binder stated, "We thank Mr. Lamadrid for working with us as we expanded into vertically integrated operations, and seeing
us through the entire process of acquiring Oasis."
Invictus MD Strategies Corp. (OTC: IVITF) owns and operates two cannabis production facilities, both with sales
licenses, under the ACMPR in Canada, with the vision of producing a variety of high quality and
low-cost cannabis products to the global market, as regulations permit. Recently, the Company announced that it has entered into
a binding letter of intent to acquire 100% of the issued and outstanding shares of a medical clinic and cannabis retail company
that operates medical clinics in, Alberta, and is awaiting final review and approval for a
retail cannabis license from the Alberta Gaming and Liquor Commission. The medical clinics' patient-first business model features
educators and physicians on-site to educate patients about medical cannabis and how to access it safely in Canada. In four easy steps, patients can see a physician, access educational support, and register with a
licensed producer to begin receiving product. The cannabis clinic has 3,400 patients registered under Access to Cannabis for
Medical Purposes Regulations, providing a direct channel to Invictus owned Licensed Producers, fully licensed under ACMPR.
Vitality Biopharma, Inc. (OTCQB: VBIO) is dedicated to unlocking the power of cannabinoids for the treatment of serious
neurological and inflammatory disorders. On June 20, 2018, the Company announced that it has
received approval from both the U.S. Drug Enforcement Administration (DEA) and the State of California Research Advisory Panel
which permits the Company to continue development of its novel cannabinoid pharmaceutical prodrugs. Vitality initially worked
with the DEA to ensure adequate on-site measures are in place to prevent diversion of Schedule I controlled substances, the most
regulated tier of controlled substances in the US. In addition, the California Research Advisory Panel, a part of the
California Attorney General's Office, also approved Vitality's cannabinoid pharmaceutical
development activities. Vitality Biopharma's operations are in compliance with federal controlled substance regulations and are
enabling development of a novel class of cannabinoid prodrugs that avoid psychoactivity.
Lexaria Bioscience Corp. (OTCQX: LXRP) has developed and out-licenses its disruptive delivery technology that promotes
healthier ingestion methods, lower overall dosing and higher effectiveness of lipophilic active molecules. Lexaria's technology
provides increases in intestinal absorption rates; more rapid delivery to the bloodstream; and important taste-masking benefits,
for orally administered bioactive molecules including cannabinoids, vitamins, non-steroidal anti-inflammatory drugs (NSAIDs),
nicotine and other molecules. Earlier in July, the Company announced the results of the 2018 Annual General and Special Meeting.
The previously announced corporate reorganization is proceeding on schedule and has been expanded. Lexaria is forming four new
wholly-owned subsidiaries, one each for the pharmaceutical, nicotine, hemp, and cannabis industries. The division recognizing
separate industry sectors is expected to greatly assist in their evolution and growth including but not limited to research and
development and finance.
The Supreme Cannabis Company, Inc. (OTC: SPRWF) is a Canadian publicly traded company committed to providing premium
brands and products that proudly reflect its consumers, people and uniquely innovative culture. The Company's portfolio includes
its wholly-owned subsidiary and flagship brand 7ACRES. 7ACRES is a federally licensed producer of medical cannabis operating
inside a 342,000-square-foot facility in Kincardine, Ontario. On July 11,
2018, the Company announced that its wholly owned subsidiary, 7ACRES, has entered into a memorandum of understanding
("MOU") with the British Columbia Liquor Distribution Board to supply recreational cannabis to BC's private cannabis retailers.
Under the terms of the MOU, 7ACRES will supply the BCLDB with 553 kg of cannabis over a 12-month period. All 7ACRES product will
be listed in the top-tier brand category in BC - consistent with other provincial supply agreements 7ACRES has signed.
Subscribe Now! Watch us report LIVE https://www.youtube.com/FinancialBuzzMedia
Follow us on Twitter for real time Financial News Updates: https://twitter.com/financialbuzz
Follow and talk to us on Instagram: https://www.instagram.com/financialbuzz
Facebook Like Us to receive live feeds: https://www.facebook.com/Financialbuzz/
About FinancialBuzz.com
FinancialBuzz.com, a leading financial news informational web portal designed to provide the latest trends in Market News,
Investing News, Personal Finance, Politics, Entertainment, in-depth broadcasts on Stock News, Market Analysis and Company
Interviews. A pioneer in the financially driven digital space, video production and integration of social media,
FinancialBuzz.com creates 100% unique original content. FinancialBuzz.com also provides financial news PR dissemination,
branding, marketing and advertising for third parties for corporate news and original content through our unique media platform
that includes Newswire Delivery, Digital Advertising, Social Media Relations, Video Production, Broadcasting, and Financial
Publications.
Please Note: FinancialBuzz.com is not a financial advisory or advisor, investment advisor or broker-dealer and do not
undertake any activities that would require such registration. The information provided on http://www.FinancialBuzz.com (the 'Site') is either original financial news or paid advertisements provided
[exclusively] by our affiliates (sponsored content), FinancialBuzz.com, a financial news media and marketing firm enters into
media buys or service agreements with the companies which are the subject to the articles posted on the Site or other editorials
for advertising such companies. We are not an independent news media provider and therefore do not represent or warrant that the
information posted on the Site is accurate, unbiased or complete. FinancialBuzz.com receives fees for producing and presenting
high quality and sophisticated content on FinancialBuzz.com along with other financial news PR media services. FinancialBuzz.com
does not offer any personal opinions, recommendations or bias commentary as we purely incorporate public market information along
with financial and corporate news. FinancialBuzz.com only aggregates or regurgitates financial or corporate news through our
unique financial newswire and media platform. For CLS Holdings USA Inc. financial news
dissemination and PR services, FinancialBuzz.com has been compensated five thousand dollars by the
company. Our fees may be either a flat cash sum or negotiated number of securities of the companies featured on this editorial or
site, or a combination thereof. The securities are commonly paid in segments, of which a portion is received upon engagement and
the balance is paid on or near the conclusion of the engagement. FinancialBuzz.com will always disclose any compensation in
securities or cash payments for financial news PR advertising. FinancialBuzz.com does not undertake to update any of the
information on the editorial or Site or continue to post information about any companies the information contained herein is not
intended to be used as the basis for investment decisions and should not be considered as investment advice or a recommendation.
The information contained herein is not an offer or solicitation to buy, hold or sell any security. FinancialBuzz.com, members
and affiliates are not responsible for any gains or losses that result from the opinions expressed on this editorial or Site,
company profiles, quotations or in other materials or presentations that it publishes electronically or in print. Investors
accept full responsibility for any and all of their investment decisions based on their own independent research and evaluation
of their own investment goals, risk tolerance, and financial condition. FinancialBuzz.com. By accessing this editorial and
website and any pages thereof, you agree to be bound by the Terms of Use and Privacy Policy, as may be amended from time to time.
None of the content issued by FinancialBuzz.com constitutes a recommendation for any investor to purchase, hold or sell any
particular security, pursue a particular investment strategy or that any security is suitable for any investor. This publication
is provided by FinancialBuzz.com. Each investor is solely responsible for determining whether a particular security or investment
strategy is suitable based on their objectives, other securities holdings, financial situation needs, and tax status. You agree
to consult with your investment advisor, tax and legal consultant before making any investment decisions. We make no
representations as to the completeness, accuracy or timeless of the material provided. All materials are subject to change
without notice. Information is obtained from sources believed to be reliable, but its accuracy and completeness are not
guaranteed. For our full disclaimer, disclosure and Terms of Use, please visit: http://www.financialbuzz.com .
For further information:
info@financialbuzz.com
+1-877-601-1879
SOURCE FinancialBuzz.com